<p>To ask the Secretary of State for Health and Social Care, with reference to the announcement from the US Food and Drug Administration on the poor efficacy of Innova covid-19 tests, whether he has plans for the (a) authorisation of alternative covid-19 rapid lateral flow tests, including those being produced in the UK and (b) extension of the exceptional use authorisation from the Medicines and Healthcare products Regulatory Authority following the extension of covid-19 restrictions.</p>